Advances in imaging head and neck tumours

Current Opinion in Oncology

Volumn 18, Issue 3, 2006, Pages 234-239

  Lemort, Marc ^a   Canizares, A Christina ^a   Kampouridis, Stelios ^b  

^a JULES BORDET INSTITUTE   (Belgium)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Computed tomography; Head and neck cancer; Imaging; Magnetic resonance imaging; Magnetic resonance spectroscopy

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; GADOLINIUM CHELATE; GADOMER 17; INDIAN INK; SUPERPARAMAGNETIC IRON OXIDE;

CANCER RADIOTHERAPY; CANCER SIZE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HEAD AND NECK CANCER; HEAD AND NECK TUMOR; HUMAN; IMAGE QUALITY; LYMPH NODE METASTASIS; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TUMOR VASCULARIZATION;

EID: 33646710608     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cco.0000219251.15041.b1     Document Type: Review

References (29)

1. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004; 233:93-100. This article illustrates the complexity of morphological information and tissue characterization using different imaging methods; the results, however, apply to large-sized tumours.
2. Chong V, Zhou J, Khoo JB, et al. Nasopharyngeal carcinoma tumor volume measurement. Radiology 2004; 231:914-921.
3. Hansen EK, Bucci MK, Quivey JM, et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006; 64:355-362. This article provides rationale for performing additional CT scans during the course of conformational radiotherapy.
4. Chooi WK, Woodhouse N, Coley SC, Griffiths PD. Pediatric head and neck lesions: assessment of vascularity by MR digital subtraction angiography. AJNR Am J Neuroradiol 2004; 25:1251-1255.
5. Ziyeh S, Strecker R, Berlis A, et al. Dynamic 3D MR angiography of intra- and extracranial vascular malformations at 3T: a technical note. AJNR Am J Neuroradiol 2005; 26:630-634. An excellent paper which describes in a comprehensive manner the performance of three-dimensional MRA combined with parallel imaging at 3 T.
6. Van den Berg R, Schepers A, de Bruine FT, et al. The value of MR angiography techniques in the detection of head and neck paragangliomas. Eur J Radiol 2004; 52:240-245. This study assesses different MRA techniques for the diagnosis of paragangliomas.
7. Jordan BF, Runquist M, Raghunand N, et al. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1A using PX-478. Neoplasia 2005; 7:475-485. This article shows a potentially useful combination of DCE-MRI and diffusion techniques for evaluation of treatment response in an animal model.
8. Bentzen L, Vestergaard-Poulsen P, Nielsen T, et al. Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor. Int Radiation Oncology Biol Phys 2005; 61:1208-1215.
9. Leach MO, Brindle KM, Evelhoch JL, et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005; 92:1599-1610. This paper reports on a workshop of an advisory committee of the Drug Development Office, Cancer Research UK and provides clear discussion of the potential of DCE-MRI and recommendations for its use in pharmacological research.
10. Rehman S, Jayson GC. Molecular imaging of antiangiogenic agents. The Oncologist 2005; 10:92-103. This paper gives an interesting and clear review of molecular imaging methods owing to the evaluation of antiangiogenic agents, with a particular emphasis on DCE-MRI.
11. Morgan B, Thomas AL, Drevs J, et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 2003; 21: 3955-3964.
12. King AD, Yeung DK, Ahuja AT, et al. In vivo 1 H MR spectroscopy of thyroid carcinoma. Eur J Radiol 2005; 54:112-117. This article suggests that MRS could be useful for predicting tumour aggressiveness/differentiation in vivo.
13. King AD, Yeung DK, Ahuja AT, et al. In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. Am J Neuroradiol 2004; 25: 484-490. This article shows the feasibility of 1H MRS in the head and neck for nasopharyngeal cancer.
14. Casselman JW. Clinical applications: imaging of morphology. High resolution imaging of the skull base and larynx. In: Schoenberg SO, Dietrich O, Reiser MF, editors. Parallel imaging in clinical applications. Berlin: Springer (in press).
15. De Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000; 110:397-401.
16. Loh KS, Brown DH, Baker JT, et al. A rational approach to pulmonary screening in newly diagnosed head and neck cancer. Head Neck 2005; 27:990-994. As the title says, this paper presents 'a rational approach to pulmonary screening' following clinical parameters such as the anatomic localization of the primary tumour and TNM classification.
17. Douglas WG, Rigual NR, Giese W, et al. Advanced soft palate cancer: the clinical importance of the parapharyngeal space. Otolaryngol Head Neck Surg 2005; 133:66-69.
18. Po Wing Yuen A, Lam KY, Lam LK, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma: a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 2002; 24:513-520.
19. Lam P, Au-Yeung KM, Cheng PW, et al. Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer. AJR Am J Roentgenol 2004; 182:803-808. This prospective study demonstrates a significant correlation between radiologic tumor thickness as measured on contrast-enhanced T1-weighted images and histologic tumor thickness.
20. Thoeny HC, Delaere PR, Hermans R. Correlation of local outcome after partial laryngectomy with cartilage abnormalities on CT. AJNR Am J Neuroradiol 2005; 26:674-678; erratum 986. Even though it is based on a relatively small series, this paper suggests that cartilage abnormalities on CT do not preclude speech-preserving surgery.
21. Becker M, Zbaren P, Laeng H, et al. Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology 1995; 194:661-669.
22. Ljumanovic R, Langendijk JA, Schenk B, et al. Supraglottic carcinoma treated with curative radiation therapy: identification of prognostic groups with MR imaging. Radiology 2004; 232:440-448. This retrospective study shows the MR abnormalities which are predictors of local outcome in supraglottic carcinoma treated with radiation therapy.
23. Koral K, Sayre J, Bhuta S, et al. Recurrent pleomorphic adenoma of the parotid gland in pediatric and adult patients: value of multiple lesions as a diagnostic indicator. AJR Am J Roentgenol 2003; 180:1171-1174.
24. Ikeda M, Motoori K, Hanazawa T, et al. Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation. AJNR Am J Neuroradiol 2004; 25:1256-1262. An exhaustive correlation between the MRI findings and the histopathology of Warthin tumour of the parotid gland.
25. Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003; 24:1627-1634.
26. Anzai Y. Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond. Top Magn Reson Imaging 2004; 15:103-111. An excellent description of the potential applications of SPIO MR contrast agents.
27. Asthana S, Deo SV, Shukla NK, et al. Intraoperative neck staging using sentinel node biopsy and imprint cytology in oral cancer. Head Neck 2003; 25:368-372.
28. Nason RW, Torchia MG, Morales CM, Thliveris J. Dynamic MR lymphangiography and carbon dye for sentinel lymph node detection: a solution for sentinel lymph node biopsy in mucosal head and neck cancer. Head Neck 2005; 27:333-338. A comprehensive description of the application of the sentinel lymph node technique in mucosal head and neck cancer in a pig model using dynamic MR lymphangiography.
29. Yabuuchi H, Kuroiwa T, Fukuya T, et al. Traumatic neuroma and recurrent lymphadenopathy after neck dissection: comparison of radiologic features. Radiology 2004; 233:523-529. This study clearly exposes statistically proved imaging criteria which can help in the differential diagnosis of recurrent lymphadenopathy after neck dissection.